Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar(®) Gel) for Persistently Active Systemic Lupus Erythematosus

INTRODUCTION: We assessed patient-reported outcomes from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection (RCI; Acthar(®) Gel) in patients with persistently active systemic lupus erythematosus (SLE) despite treatment with moderate-dose glucocort...

Descripción completa

Detalles Bibliográficos
Autores principales: Askanase, Anca D., Wan, George J., Panaccio, Mary P., Zhao, Enxu, Zhu, Julie, Bilyk, Roman, Furie, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991053/
https://www.ncbi.nlm.nih.gov/pubmed/33687687
http://dx.doi.org/10.1007/s40744-021-00294-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991053/
https://www.ncbi.nlm.nih.gov/pubmed/33687687
http://dx.doi.org/10.1007/s40744-021-00294-z

Ejemplares similares